TAG:
diagnostic testing
Qualigen’s POL PSA Test Cleared for Sale by FDA
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPackâ„¢ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
Neurology is Test Focus For Athena Diagnostics
CEO SUMMARY: There are few examples of laboratory companies focused on a single medical specialty,a business model that is expected to become more common in coming years. One such company is Athena Diagnostics. For 12 years, this company has concentrated on providing diagnostic testing fo…
Beckman Coulter’s Strategy Reflects Consolidation Trends
CEO SUMMARY: Rapid changes to the clinical laboratory industry had equally profound impact upon the major diagnostic companies. At Beckman Coulter, Inc., market forces triggered a decade of acquisitions and internal consolidation.The company looks very different today than it did ten year…
Express Scripts, InformInvestor.com, UroCor, Bio-Reference Laboratories
PRESCRIPTION DRUG SPENDING HITS A RECORD INCREASE OF 17.4% IN 1999 Just-released data from Express Scripts, Inc. indicates that spending on prescription drugs increased by a record 17.4% during 1999. This compares to a 9.6% spending increase for drugs in 1998. As most lab e…
Luminex Raises $83 Mil In Public Stock Offering
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: During the past year, Luminex Corporation moved swiftly to push its LabMAPâ„¢ multiplex testing technology into the bioassay marketplace. It found high interest among companies in the pharmaceutical, diagnostics, and bioresearch industries. Luminex executives say that a numbe…
LabCorp Buys Two More California Laboratories
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: Laboratory Corporation of America is serving notice that it intends to increase its competitive presence in California, the largest market for diagnostic testing in the United States. It recently signed agreements to purchase two respected independent laboratory companies, on…
Hospital Labs To Regain Pre-Eminence in Coming Years
By Robert Michel | From the Volume VII No. 6 – April 17, 2000 Issue
CEO SUMMARY: During the past five years, powerful forces in the healthcare marketplace positioned hospital-based laboratories to once again become the dominant force in laboratory testing. But this can only occur if today’s generation of hospital laboratory directors and clinical pathol…
Independent California Lab Decides to Exit Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Market forces in California continue to put independent laboratories under sustained financial stress. One laboratory owner decided it was an auspicious time to sell his lab. That sale, of POISONLAB to Laboratory Corporation of America, was announced earlier this month. There…
Quantum Dots Targeting Multiplexed Bioassays
By Robert Michel | From the Volume VII No. 3 – February 14, 2000 Issue
CEO SUMMARY: Here’s another exciting new technology which promises to expand the capabilities of diagnostic testing while lowering laboratory costs. Based on research originally done during the 1970’s, quantum dotsâ„¢ are nanometer-sized semiconductors with unique properties. Quantum …
Epitope, LabOne, CARESIDE, Quest, Structural Bioinformatics, UroCor
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
EPITOPE RAIDS LABONE FOR NEW PRESIDENT/CEO; READIES DRUGS OF ABUSE MARKET LAUNCH DURING THE YEAR 2000, Epitope, Inc., based in Portland, Oregon, plans to introduce a drugs of abuse test based on its patented OraSure® oral collection technology. To aid in this new product l…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized